Ardelyx Inc (ARDX)

Ardelyx Inc (ARDX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $842M; returns 1 day -3.8%, 1 week -0.3%, 1 year -39.1%.

Ardelyx Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative, first-in-class medicines for significant unmet medical needs, primarily in gastrointestinal and cardiorenal diseases.

Groups ARDX belongs to

• Biopharmaceutical
• Commercial Stage Biotech
• Gastroenterology
• Pharmaceuticals
• Nephrology
• Healthcare
• Commercial Stage
• Unmet Medical Needs
• Biotechnology
• Digestive Health

ARDX financial model: income statement, cash flow and balance sheet